In vitro effects of magnesium sulfate in isolated intrapulmonary and mesenteric arteries of piglets

Pediatric Research

Volumn 39, Issue 6, 1996, Pages 1107-1112

  Villamor, E ^a   Perez Vizcaino F ^b   Ruiz, T ^a   Tamargo, J ^b   Moro, M ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b SCHOOL OF MEDICINE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; CALCIUM ION; MAGNESIUM ION; MAGNESIUM SULFATE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; POTASSIUM CHLORIDE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; MALE; MESENTERIC ARTERY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; SMOOTH MUSCLE TONE; SWINE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0029999192     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199606000-00029     Document Type: Article

References (31)

1. Roberts JD, Shaul PW 1993 Advances in the treatment of persistent pulmonary hypertension of the newborn. Pediatr Clin North Am 40:983-1004
2. Ryan CA, Finer NN, Barrington KJ 1994 Effects of magnesium sulphate and nitric oxide in pulmonary hypertension induced by hypoxia in newborn piglets. Arch Dis Child 71:F151-F155
3. Roberts Jr JD, Chen T, Wain J, Polaner D, Dupuy P, Zapol WM 1992 Nitric oxide gas is a selective pulmonary vasodilator in the newborn lamb during hypoxemia and acidosis. Pediatr Res 31:A1279
4. Roberts JD, Polaner DM, Lang P, Zapol WM 1992 Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340:819-820
5. Kinsella JP, Neish SR, Shatter E, Abman SH 1992 Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340:819-820
6. Drummond WE, Lock JE 1984 Neonatal "pulmonary vasodilator" drugs. Dev Pharmacol Ther 7:1-20
7. Altura BT, Altura BM 1981 Magnesium ions and contraction of vascular smooth muscles: relationship to some vascular diseases. Fed Proc 40:2672-1679
8. 2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels. Can J Physiol Pharmacol 65:729-745
9. Iseri LT, French JH 1984 Magnesium: nature's physiological calcium blocker (Editorial). Am Heart J 108:188-193
10. Rüegg UT, Wallnofer A, Weir S, Cauvin C 1989 Receptor-operated calcium-permeable channels in vascular smooth muscle. J Cardiovasc Pharmacol 14(Suppl 6):S49-S58
11. Gold ME, Buga GM, Wood KS, Byrns RE, Chaudhuri G, Ignarro LJ 1990 Antagonistic modulatory roles of magnesium and calcium on release of endothelium derived relaxing factor and smooth muscle tone. Circ Res 66:355-366
12. Ku DD, Ann HS 1987 Magnesium deficiency produces endothelium-dependent vasorelaxation in canine coronary arteries. J Pharmacol Exp Ther 241:961-966
13. Ku DD, Ann HS 1991 Differential effects of magnesium on basal and agonist-induced EDRF in canine coronary arteries. J Cardiovasc Pharmacol 17:999-1006
14. Flink EB, Dehdia HV, Dinsmore J, Doshi HM, Banks D, Hshieh P 1992 High-dose magnesium sulfate attenuates pulmonary oxygen toxicity. Crit Care Med 20:1692-1698
15. Nadler JL, Goodson S, Rude RK 1987 Evidence that prostacyclin mediates the vascular action of magnesium in humans. Hypertension 9:379-383
16. 4 in sheep. Pediatr Res 27:351A
17. Anderson ME, Burnette TM, Geiser DR, Janjindamai W 1994 Magnesium attenuates pulmonary hypertension due to hypoxia and group B streptococci. J Appl Physiol 77:751-756
18. Abu-Osba YK, Galal O, Manasra K, Rejjal A 1992 Treatment of severe persistent pulmonary hypertension of the newborn with magnesium sulfate. Arch Dis Child 67:31-35
19. Tolsa J-F, Cotting J, Sekarski N, Payot M, Micheli J-L, Calame A 1995 Magnesium sulphate as an alternative and safe treatment for severe persistent pulmonary hypertension of the newborn. Arch Dis Child 72:F184-F187
20. Perez-Vizcaino F, Casis O, Rodriguez R, Gomez LA, Garcia Rafanell J, Tamargo J 1993 Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle. Br J Pharmacol 110:1165-1171
21. Villamor E, Perez-Vizcaino F, Ruiz T, Leza JC, Moro M, Tamargo J 1995 Group B Streptococcus and E. coli LPS-induced NO-dependent hyporesponsiveness to noradrenaline in isolated intrapulmonary arteries of neonatal piglets. Br J Pharmacol 115:261-266
22. McLean RM 1994 Magnesium and its therapeutic uses: a review. Am J Med 96:63-76
23. Levy M, Tulloh RMR, Komai H, Stuart-Smith K, Haworth SG 1995 Maturation of the contractile response and its endothelial modulation in newborn porcine intrapulmonary arteries. Pediatr Res 38:25-29
24. 2+. J Clin Invest 89:1988-1994
25. 2+ in isolated human cerebral arteries. Eur J Pharmacol 229:83-89
26. Dickstein PJ, Trintade O, Goldberg RN, Bancalari E 1984 The effect of calcium antagonists on hypoxic pulmonary hypertension in the piglet. Pediatr Res 18:1262-1265
27. Dobyns EL, Wescott JA, Kennaugh JM, Ross MN, Stenmark KR 1994 Eicosanoids decrease with successful extracorporeal membrane oxygenation therapy in neonatal pulmonary hypertension. Am J Respir Crit Care Med 149:873-880
28. Warner AE, Molina R, Brain JD 1987 Uptake of bloodborne bacteria by pulmonary intravascular macrophages and consequent inflammatory responses in sheep. Am Rev Respir Dis 136:683-693
29. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM 1991 Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83:2038-2047
30. Altura BT, Altura BM 1987 Endothelium-dependent relaxation in coronary arteries requires magnesium ions. Br J Pharmacol 91:449-451
31. 2+ levels. J Vasc Med Biol 1:85A